Submitted by Anonymous (not verified) on 25 August 2023 - 14:27
Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Osteoporosis, Postmenopausal;Osteoporosis, Date of authorisation: 12/12/2022, Revision: 2, Status: Authorised
Source: